{"id":140463,"date":"2024-12-10T15:10:10","date_gmt":"2024-12-10T09:40:10","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=140463"},"modified":"2024-12-10T15:12:27","modified_gmt":"2024-12-10T09:42:27","slug":"pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/","title":{"rendered":"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-442277292\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day&#8217;s trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-470702068\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of 2,109.53 Crores on Tuesday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/SURAKSHA\" target=\"_blank\" rel=\"noreferrer noopener\">Suraksha Diagnostic Ltd<\/a><\/strong> fell by 3.5 percent making a low of Rs 402.10 compared to its previous closing price of Rs 410.70.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What happened<\/strong><\/h2><p>According to the company filing,&nbsp; Nippon India mutual fund, a domestic institutional investor, has acquired a fresh stake of 28.12 lakh equity shares which is equivalent to 5.4 percent of the company.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company<\/strong><\/h2><p>Suraksha Diagnostics Ltd is a prominent healthcare company specializing in diagnostic services was founded with the mission to provide accessible, affordable and high-quality healthcare solutions. The company offers a wide range of services, including pathology tests, radiology imaging and preventive health checkups. With a focus on accuracy and patient care, Suraksha Diagnostics employs state-of-the-art medical equipment and a team of skilled professionals, including pathologists, radiologists, and technologists.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1156433990\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company strives to make healthcare services convenient and reliable, with a strong emphasis on delivering quick results. Suraksha Diagnostics has expanded its presence across various locations, catering to both urban and rural populations, and remains committed to maintaining high standards in medical testing. The company had 283 doctors across various segments.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials&nbsp;<\/strong><\/h2><p>The company&#8217;s revenue rose by 15 percent from Rs 190.13 crore in FY22-23 to Rs 218.70 crore in FY23-24. Meanwhile, Net profit increased by 281 percent from Rs 6.06 crore to Rs 23.12 crore during the same period.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Key Financial ratios<\/strong><\/h2><p>Suraksha Diagnostics Ltd had a Return on Equity (RoE) of 14.09 percent as of FY23-24 and a Return on Capital Employed (RoCE) of 21.46 percent as of FY23-24 and a P\/E ratio of 83.22. Furthermore, the company&#8217;s net debt-to-equity ratio is 0.20 as of FY23-24.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Revenue Segmentation<\/strong><\/h2><p>As of FY24, the company earned its revenue from operations from Radiology which contributed around 46.03 percent, Pathology contributed around 53.30 percent, Doctor Consultation at 0.49 percent, and Covid Tests at 0.18 percent. Suraksha contributes around 6.17 percent from the B2B segment in FY24 which is nearly more than half from 3.99 percent in FY23.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding Pattern<\/strong><\/h2><p>Suraksha Diagnostics Ltd. has a well-diversified shareholding structure. As of December 2024, The promoters hold 48.78%, while Foreign Institutional Investors (FIIs) own 15.64% and Domestic Institutional Investors (DIIs) hold 13.99%. The remaining 21.59% is owned by the public, it reflects a balanced mix of promoter control and investor confidence from both institutional and retail shareholders.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-990163613\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-2430187825\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day&#8217;s trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund. Price action With a market capitalization of 2,109.53 Crores on Tuesday, the shares of Suraksha Diagnostic Ltd fell by 3.5 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25298,15654,948,936,25296,25297],"class_list":["post-140463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-nippon-india-fund-acquired-stake","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-suraksha-diagnostic","tag-suraksha-diagnostic-latest-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day&#039;s trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar\" \/>\n<meta property=\"og:description\" content=\"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day&#039;s trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-10T09:40:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-10T09:42:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/\",\"name\":\"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-12-10T09:40:10+00:00\",\"dateModified\":\"2024-12-10T09:42:27+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day's trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar - Trade Brains Features","description":"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day's trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar","og_description":"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day's trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-10T09:40:10+00:00","article_modified_time":"2024-12-10T09:42:27+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/","name":"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-12-10T09:40:10+00:00","dateModified":"2024-12-10T09:42:27+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"In Tuesday\u2019s trading session, the shares of one of the leading Healthcare companies in India almost fell by 3.5 percent day's trade despite the acquisition of a 5.4% stake from the Nippon India mutual fund.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-which-nippon-india-fund-acquired-5-4-stake-to-keep-on-your-radar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock in which Nippon India Fund acquired 5.4% stake to keep on your radar"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=140463"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140463\/revisions"}],"predecessor-version":[{"id":140464,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140463\/revisions\/140464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=140463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=140463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=140463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}